Neurology

ITSN1 gene variant raises Parkinson’s risk tenfold, with links to autism. Breakthrough study reveals dual neurological threat.

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

Ultrasound therapy boosts cognition in younger Alzheimer’s patients. Study highlights TPS as a potential add-on treatment.

Parkinson’s disease cases are set to double by 2050 due to ageing populations. Study highlights urgent need for action.

Gut microbiome study identifies microbial ratio linked to multiple sclerosis severity, offering potential for diagnostics and therapies.

Low-dose semaglutide reduces alcohol cravings and some drinking behaviours in adults with alcohol use disorder.

Nasal spray shows promise in treating traumatic brain injury by reducing inflammation and enhancing immune cell function in mouse models.

New 4D brain map unveils early warning signs and potential therapeutic targets for multiple sclerosis, offering hope for improved treatments.